Clinical Trials

Phase I clinical trial was approved by MFDS(formerly known as KFDA) in 2003, and was successfully completed in 2004. 10 out of 15 patients with terminal cancer had reduction in tumor size or their tumor stopped growing.

Phase II clinical trial was approved by MFDS in 2007.